Showing results (1531-1540 of 2,063) with videos related to

Sort By:
Pageof 207
Matrix Biology : Journal of the International Society for Matrix Biology|April 29, 1998
Overview of matrix metalloproteinase expression in cultured human cellsT A Giambernardi, G M Grant, G P Taylor, et al.
Perioperative Care and Operating Room Management|September 10, 2021
ROUTINE USE OF SUGAMMADEX DOES NOT SHORTEN PACU LENGTH OF STAY: A PROSPECTIVE DOUBLE-BLINDED RANDOMIZED CONTROLLED TRIALGermán Echeverry, Lily Polskin, Luis E Tollinche, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 22, 2011
Blood (1->3)-beta-D-glucan as a diagnostic test for HIV-related Pneumocystis jirovecii pneumoniaPaul E Sax, Lauren Komarow, Malcolm A Finkelman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 3, 2018
Acquisition of Multidrug-Resistant Human Immunodeficiency Virus Type 1 Infection in a Patient Taking Preexposure ProphylaxisDonn J Colby, Eugene Kroon, Carlo Sacdalan, et al.
The Journal of Antimicrobial Chemotherapy|July 8, 2019
A systematic review of the genetic mechanisms of dolutegravir resistanceSoo-Yon Rhee, Philip M Grant, Philip L Tzou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 18, 2000
Reversal of human immunodeficiency virus type 1-associated hematosuppression by effective antiretroviral therapyS S Huang, J D Barbour, S G Deeks, et al.
AIDS (London, England)|July 9, 1999
Time course of cerebrospinal fluid responses to antiretroviral therapy: evidence for variable compartmentalization of infectionS Staprans, N Marlowe, D Glidden, et al.
AIDS (London, England)|January 31, 2003
Persistence of drug-resistant HIV-1 after a structured treatment interruption and its impact on treatment responseSteven G Deeks, Robert M Grant, Terri Wrin, et al.
The Journal of Infectious Diseases|October 6, 2005
Interruption of treatment with individual therapeutic drug classes in adults with multidrug-resistant HIV-1 infectionSteven G Deeks, Rebecca Hoh, Torsten B Neilands, et al.
Immunology|June 13, 2006
Cross-priming utilizes antigen not available to the direct presentation pathwayKeri B Donohue, Jean M Grant, Eric F Tewalt, et al.
Pageof 207